Last update 08 May 2025

DGKA x 5-HT2 receptor

Basic Info

Related Targets
DGKA5-HT2 receptor

Related

1
Drugs associated with DGKA x 5-HT2 receptor
Ritanserin
Target
5-HT2 receptor x DGKA
Mechanism
5-HT2 receptor antagonists [+1]
Active Org.
Università degli Studi del Piemonte Orientale Amedeo AvogadroUniversità degli Studi del Piemonte Orientale Amedeo Avogadro
Originator Org.
Janssen Global Services LLCJanssen Global Services LLC
Active Indication
X-Linked Lymphoproliferative Disorder
Inactive Indication
Cocaine-Related Disorders
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with DGKA x 5-HT2 receptor
NCT00000187
/ CompletedPhase 2IIT
Ritanserin in Treatment of Cocaine Dependence
100 Clinical Results associated with DGKA x 5-HT2 receptor
Login to view more data
100 Translational Medicine associated with DGKA x 5-HT2 receptor
Login to view more data
0 Patents (Medical) associated with DGKA x 5-HT2 receptor
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free